The Charcot-Marie-Tooth Disease Report is based on Whole Genome Sequencing Test. As such, it analyzesall Common and Rare Variantsassociated with Charcot-Marie-Tooth Disease instead of a limited set of genes, like old genetic target panels.
Charcot-Marie-Tooth disease encompasses a group of disorders known as hereditary sensory and motor neuropathies that damage the peripheral nerves. Damage to the peripheral nerves that worsen over time may result in alteration or loss of sensation and wasting (atrophy) of muscles in the feet, legs, and hands. This disease can lead to different outcomes, from insignificant variations in motor skills to limb atrophy, with a series of related effects such as difficulty walking and muscle pain.
Along with environmental factors,Genetics plays a key rolein the regulation of Charcot-Marie-Tooth Disease.